<DOC>
	<DOCNO>NCT00943462</DOCNO>
	<brief_summary>Positron Emission Tomography-Computed Tomography ( PET-CT ) injection 18F-fluoroethylcholine ( FEC ) could useful tool evaluation follow-up patient diagnose glioblastoma multiforme ( GBM ) treat radiotherapy temozolomide allow , example , distinction necrosis tumour tissue . This tool could help clinician make therapeutic decision GBM patient .</brief_summary>
	<brief_title>Study 18F-FEC Positron Emission Tomography-Computed Tomography ( PET-CT ) Imaging GBM</brief_title>
	<detailed_description />
	<mesh_term>Glioblastoma</mesh_term>
	<mesh_term>Astrocytoma</mesh_term>
	<mesh_term>Temozolomide</mesh_term>
	<mesh_term>Dacarbazine</mesh_term>
	<criteria>Inclusion criterion : Age 18 70 year age Histological diagnosis GBM ( grade IV astrocytoma base World Health Organization [ WHO ] classification ) No previous radiotherapy chemotherapy No history previous neoplasm Inoperable patient ( tumour place , biopsy ) KPS ≥ 70 Adequate hematological , renal hepatic function Absolute neutrophil count ≥ 1,500/mm3 Platelets ≥ 100,000 per mm3 Serum creatinine ≤ 1.5 time upper limit normal laboratory measure Total bilirubin ≤ 1.5 time upper limit normal laboratory measure Liver enzymes &lt; 3 time upper limit normal laboratory measure Patients corticosteroid must receive stable decrease dose 14 day precede randomization Consent form sign patient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2011</verification_date>
</DOC>